Last reviewed · How we verify

NCT07430709

Validation of the STS Device for Pulmonary Function Test in Pediatric Population

Not yet recruiting NA Last updated 24 February 2026
What this trial tests

NA trial testing Spirometry Test System (STS) in Pulmonary Function Testing in 160 participants. Not yet recruiting.

Timeline
5 March 2026
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorTechnopulm
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment160
Start date5 March 2026
Primary completion31 December 2026
Estimated completion31 December 2026

Drugs / interventions tested

Conditions studied

Sponsor

Technopulm

Who can join

Adults 7 to 17, any sex, with Pulmonary Function Testing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective, single-arm, self-controlled validation study aims to evaluate the accuracy and safety of the Spirometry Test System (STS) handheld device in measuring pulmonary parameters in pediatric subjects aged 7-17 years. Each participant will undergo pulmonary function testing using both conventional laboratory methods (spirometry and body plethysmography) and the STS device in randomized order. Agreement between methods, repeatability of measurements, and device safety will be assessed. The study will be conducted at Children's National Hospital, Washington, USA

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07430709.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing